Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Radolf

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
A diffusible cytotoxin of Haemophilus ducreyiL D Cope, S Lumbley, J L Latimer, et al.
The New England Journal of Medicine|July 31, 1997
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study GroupR T Rolfs, M R Joesoef, E F Hendershot, et al.
The Journal of Biological Chemistry|June 30, 2000
Neelaredoxin, an iron-binding protein from the syphilis spirochete, Treponema pallidum, is a superoxide reductaseT Jovanović, C Ascenso, K R Hazlett, et al.
Minerva Medica|April 25, 2009
Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatmentG P Wormser, E D Shapiro, J J Halperin, et al.
The New England Journal of Medicine|October 5, 2007
A critical appraisal of "chronic Lyme disease"Henry M Feder, Barbara J B Johnson, Susan O'Connell, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1997
A diffusible cytotoxin of Haemophilus ducreyiL D Cope, S Lumbley, J L Latimer, et al.
The New England Journal of Medicine|July 31, 1997
A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. The Syphilis and HIV Study GroupR T Rolfs, M R Joesoef, E F Hendershot, et al.
The Journal of Biological Chemistry|June 30, 2000
Neelaredoxin, an iron-binding protein from the syphilis spirochete, Treponema pallidum, is a superoxide reductaseT Jovanović, C Ascenso, K R Hazlett, et al.
Minerva Medica|April 25, 2009
Analysis of a flawed double-blind, placebo-controlled, clinical trial of patients claimed to have persistent Lyme disease following treatmentG P Wormser, E D Shapiro, J J Halperin, et al.
The New England Journal of Medicine|October 5, 2007
A critical appraisal of "chronic Lyme disease"Henry M Feder, Barbara J B Johnson, Susan O'Connell, et al.
Pageof 12